Skip to main content
Caplight Logo









3D Organon

3D Organon

Private
Gold CoastHealthcare & Life Scienceshttps://www.3dorganon.com/

Last Round

VC Round

Sep 1, 2021

Company Overview

3D Organon is a healthtech company that provides a medical and healthcare education platform for teaching and learning anatomy across virtual reality, desktop, tablet, and mobile devices.

Sector

Healthcare & Life Sciences

Verticals

AR/VR Experiences, Medical Imaging, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Keywords

medical educationanatomy softwarevirtual reality anatomyXR anatomymedical VRaugmented reality anatomyclinical training3D visualizationanatomy simulationedtechmedical training softwarevirtual dissectionVR traininghealthcare simulationmedical metaverse

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

3D Organon Comparables

Compare 3D Organon with similar companies based on industry and business-model similarity.

3D Organon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medicalholodeck AG
86%
Reed Business Information
83%
Cengage Group
79%

3D Organon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 1, 2021
Early FundingJul 1, 2021

Key People

Founding team and executive leadership

Athanasios Raikos

CEO Founder

Founding Team

Panagiota Kordali

COO Managing Director, Academic Advisor, Medical Author

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 59% MoM, reaching 15.2K.

  • Jan 2, 2026

    Monthly visitors increased 43% MoM.

Recent news

Latest coverage and updates

  • attends_eventAug 4, 2026

    3D Organon attends event IFAA 2026.

3D Organon Filings

Explore SEC and related filing metadata, where available.

3D Organon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 3D Organon's valuation, stock price, and market status.

Is 3D Organon a public or private company?

3D Organon is a private company.

What is the current stock price of 3D Organon?

3D Organon is a private company with no public stock price. Caplight tracks 3D Organon's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is 3D Organon worth (valuation)?

Valuation information for 3D Organon is not publicly available.

Can I buy 3D Organon stock?

3D Organon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 3D Organon's last funding round?

3D Organon's most recent funding round was VC Round on September 1, 2021.

Who are the main investors in 3D Organon?

Investor information for 3D Organon is not publicly disclosed.

Will 3D Organon IPO soon?

No public IPO plans have been announced for 3D Organon.

How can I track 3D Organon secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 3D Organon's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGold Coast
Employee Range13
Year Founded2015
Last FundingSep 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?